Technical Analysis for LLY - Eli Lilly and Company
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
NR7-2 | Range Contraction | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
Gapped Up | Strength | 0.00% | |
NR7 | Range Contraction | 1.13% | |
Gapped Down | Weakness | 1.13% | |
20 DMA Resistance | Bearish | 0.25% | |
New Uptrend | Bullish | 0.25% | |
Gapped Up | Strength | 0.25% |
Alert | Time |
---|---|
Possible NR7 | about 10 hours ago |
60 Minute Opening Range Breakout | about 11 hours ago |
Up 2% | about 13 hours ago |
Rose Above 20 DMA | about 13 hours ago |
20 DMA Resistance | about 13 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 04/30/2024
Eli Lilly and Company Description
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company's neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; bipolar depression and treatment-resistant depression; and brain imaging of beta-amyloid plaques. Its endocrinology products treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. The company's oncology products treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as cardiovascular products, which are used treat erectile dysfunction, benign prostatic hyperplasia, high cholesterol, pulmonary arterial hypertension; reduce thrombotic cardiovascular events; and used as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents; antibiotics to control enteric infections in calves and swine; products to treat canine separation anxiety; products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections; and other pharmaceutical products to treat staphylococcal and bacterial infections. The company distributes its products through independent wholesale distributors; and directly to pharmacies. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Diabetes Neuroscience Pharmaceutical Products Alzheimer's Disease Hypertension Mental Health Antibiotics Health Products Animal Health Wholesale Distributor Schizophrenia Dog Dysfunction Milk Major Depressive Disorder Psychiatric Diagnosis Psychiatry Depression Pulmonary Arterial Hypertension Cholesterol Cattle Depressive Disorder Amyloid Bacterial Infections Osteoporosis Animal Health Products Attention Deficit Hyperactivity Disorder Head And Neck Cancer Bipolar Disorder Endocrinology Benign Prostatic Hyperplasia Growth Hormone Helio Hyperactivity Disorder Hyperplasia Obsessive Compulsive Disorder Vascular Products Erectile Dysfunction Growth Hormone Deficiency Mood Disorders Percutaneous Testosterone Treatment Resistant Depression Cardiovascular Products Mesothelioma Bipolar Depression Oncology Products Panic Disorder Percutaneous Coronary Intervention Psychology Respiratory And Other Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 800.78 |
52 Week Low | 320.5763 |
Average Volume | 3,196,649 |
200-Day Moving Average | 577.96 |
50-Day Moving Average | 707.31 |
20-Day Moving Average | 764.39 |
10-Day Moving Average | 762.44 |
Average True Range | 20.45 |
RSI (14) | 56.14 |
ADX | 26.84 |
+DI | 26.97 |
-DI | 22.41 |
Chandelier Exit (Long, 3 ATRs) | 739.44 |
Chandelier Exit (Short, 3 ATRs) | 788.96 |
Upper Bollinger Bands | 791.22 |
Lower Bollinger Band | 737.56 |
Percent B (%b) | 0.47 |
BandWidth | 7.02 |
MACD Line | 12.88 |
MACD Signal Line | 18.94 |
MACD Histogram | -6.0632 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 779.81 | ||||
Resistance 3 (R3) | 780.24 | 774.96 | 776.95 | ||
Resistance 2 (R2) | 774.96 | 770.59 | 774.74 | 775.99 | |
Resistance 1 (R1) | 768.81 | 767.90 | 771.89 | 768.38 | 775.04 |
Pivot Point | 763.53 | 763.53 | 765.07 | 763.31 | 763.53 |
Support 1 (S1) | 757.38 | 759.16 | 760.46 | 756.95 | 750.28 |
Support 2 (S2) | 752.10 | 756.47 | 751.88 | 749.33 | |
Support 3 (S3) | 745.95 | 752.10 | 748.37 | ||
Support 4 (S4) | 745.52 |